Microcap Ledger Rapid Micro Biosystems, Inc. $RPID
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Laboratory Analytical Instruments
- Headquarters
- Lexington, MA
- Fiscal year end
- December 31
What the company doesAI summary of filing
Rapid Micro Biosystems develops and sells the Growth Direct platform, a fully automated system for microbial quality control testing in pharmaceutical manufacturing. The company's platform automates the detection and enumeration of microorganisms in samples from drug manufacturing facilities, providing faster results and greater accuracy than manual testing methods. Rapid Micro Biosystems generates revenue from system sales and recurring revenues through proprietary consumables and service contracts; the company has placed 190 systems and sold approximately 9 million consumables globally as of the filing date. The company is revenue-generating with a customer base including 75% of the top twenty largest pharmaceutical companies. [10-K 2026-03-12]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $16.06M | −$27.20M | −$27.76M | $14.69M | [10-Q 2026-08-07] |
| FY ended Dec 2025 | $33.59M | −$47.12M | −$31.06M | $20.03M | [10-K 2026-03-12] |
| FY ended Dec 2024 | $28.05M | −$46.89M | −$44.15M | $16.91M | [10-K 2026-03-12] |
- Quarterly cash burn
- −$13.88M
- Cash runway Estimate
- ~3.2 months
Capital structure and dilution
- Shelf registration
- S-3 filed 2023-12-15; declared effective 2023-12-26 [S-3 2023-12-15]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-24 | Kollender Richard S | exercise | 1,681 | $0.75 | [4 2026-07-24] |
| 2026-07-24 | Kollender Richard S | exercise | 1,827 | $0.75 | [4 2026-07-24] |
| 2026-07-22 | Spignesi Robert G. Jr. | exercise | 1,402 | $0.75 | [4 2026-07-24] |
| 2026-05-29 | Lowenstein Inese | grant | 12,787 | $1.96 | [4 2026-06-02] |
| 2026-05-29 | Pei Melinda Litherland | grant | 12,787 | $1.96 | [4 2026-06-02] |
| 2026-05-29 | Malloy Kirk | grant | 12,787 | $1.96 | [4 2026-06-02] |
| 2026-05-29 | Wirtjes Sean M | grant | 12,787 | $1.96 | [4 2026-06-02] |
| 2026-05-29 | Spignesi Robert G. Jr. | grant | 12,787 | $1.96 | [4 2026-06-02] |
| 2026-05-21 | Malloy Kirk | grant | 19,300 | — | [4 2026-05-26] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-14 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-08-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-07 | 10-Q | Quarterly report |
| 2026-08-07 | 8-K | Results of operations |
| 2026-05-28 | 8-K | Shareholder vote results |
| 2026-05-19 | 8-K | Material agreement entered |
| 2026-05-19 | 424B5 | Prospectus or prospectus supplement |
| 2026-05-19 | 424B5 | Prospectus or prospectus supplement |
| 2026-05-15 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-15 | 10-Q | Quarterly report |
| 2026-05-13 | 8-K | Results of operations |
| 2026-04-08 | DEF 14A | Proxy statement |
Alerts for $RPID
Email me when Rapid Micro Biosystems, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.